Evidence map›Paper›PMID 9642196›Full record

ArticleJournal of bacteriology1998

The V antigen of Yersinia pestis regulates Yop vectorial targeting as well as Yop secretion through effects on YopB and LcrG.

M L Nilles, K A Fields, S C Straley

Open access · bronzeAbstract read
In one paragraph

Article in Journal of bacteriology, 1998. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 103 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Amino acid and structural variability of Yersinia pestis LcrV protein.Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases · 2010
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

M L NillesDepartment of Microbiology and Immunology, Chandler Medical Center, University of Kentucky, Lexington 40536-0084, USA.
K A Fields
S C Straley
Albert B. Chandler Hospital · US

Funding

PLASMID PCD1-ENCODED VIRULENCE DETERMINANTS IN PLAGUER37AI021017 · NIAID · UNIVERSITY OF KENTUCKY · PI STRALEY, SUSAN C · 1995 to 2004
$1.9M
REGULATORY ROLE OF THE YERSINIA PESTIS LCRG/LCRV COMPLEXF32AI009854 · NIAID · UNIVERSITY OF KENTUCKY · PI NILLES, MATTHEW L. · 1997 to 1997
–
PLASMID PCD-ENCODED VIRULENCE DETERMINANTS IN PLAGUER01AI021017 · NIAID · UNIVERSITY OF KENTUCKY · PI STRALEY, SUSAN C · 1986 to 1994
–
NIAID NIH HHS AI09854NIAID NIH HHS AI21017NIAID NIH HHS F32 AI009854NIAID NIH HHS R37 AI021017
6 · The paper itself

Abstract

Yersinia pestis expresses a set of secreted proteins called Yops and the bifunctional LcrV, which has both regulatory and antihost functions. Yops and LcrV expression and the activity of the type III mechanism for their secretion are coordinately regulated by environmental signals such as Ca2+ concentration and eukaryotic cell contact. In vitro, Yops and LcrV are secreted into the culture medium in the absence of Ca2+ as part of the low-Ca2+ response (LCR). The LCR is induced in a tissue culture model by contact with eukaryotic cells that results in Yop translocation into cells and subsequent cytotoxicity. The secretion mechanism is believed to indirectly regulate expression of lcrV and yop operons by controlling the intracellular concentration of a secreted negative regulator. LcrG, a secretion-regulatory protein, is thought to block secretion of Yops and LcrV, possibly at the inner face of the inner membrane. A recent model proposes that when the LCR is induced, the increased expression of LcrV yields an excess of LcrV relative to LcrG, and this is sufficient for LcrV to bind LcrG and unblock secretion. To test this LcrG titration model, LcrG and LcrV were expressed alone or together in a newly constructed lcrG deletion strain, a delta lcrG2 mutant, of Y. pestis that produces low levels of LcrV and constitutively expresses and secretes Yops. Overexpression of LcrG in this mutant background was able to block secretion and depress expression of Yops in the presence of Ca2+ and to dramatically decrease Yop expression and secretion in growth medium lacking Ca2+. Overexpression of both LcrG and LcrV in the delta lcrG2 strain restored wild-type levels of Yop expression and Ca2+ control of Yop secretion. Surprisingly, when HeLa cells were infected with the delta lcrG2 strain, no cytotoxicity was apparent and translocation of Yops was abolished. This correlated with an altered distribution of YopB as measured by accessibility to trypsin. These effects were not due to the absence of LcrG, because they were alleviated by restoration of LcrV expression and secretion alone. LcrV itself was found to enter HeLa cells in a nonpolarized manner. These studies supported the LcrG titration model of LcrV's regulatory effect at the level of Yop secretion and revealed a further role of LcrV in the deployment of YopB, which in turn is essential for the vectorial translocation of Yops into eukaryotic cells.

Indexed as

Antigens, BacterialBacterial Outer Membrane ProteinsBacterial ProteinsCalciumCell SurvivalDNA PrimersEscherichia coliGenetic VectorsHeLa CellsHemolysisHumansPhenotypePlasmidsPolymerase Chain ReactionPore Forming Cytotoxic ProteinsRecombinant ProteinsAntigens, BacterialBacterial Outer Membrane ProteinsBacterial ProteinsCalciumDNA PrimersLcrG protein, YersiniaLcrV protein, YersiniaPore Forming Cytotoxic ProteinsRecombinant ProteinsYopB protein, Yersinia

Identifiers

PMID9642196
PMCPMC107298
OpenAlexW2150981003

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.